arrow
V

Vladimir Kirkin

Zurich
H指数:37
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study

肿瘤局部CD40激动与MP0317,一种FAP x CD40 DARPin,重新编程晚期实体瘤患者的肿瘤微环境: 一项开放标签,非随机,剂量递增的1期研究

2026-05-010
OAAI
Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones
2023-04-072
OAAI
A PHASE 1 STUDY TO CHARACTERIZE THE SAFETY AND TOLERABILITY OF MP0317, A TUMOR TARGETING FAP DEPENDENT CD40 AGONIST DARPIN, IN PATIENTS WITH RELAPSED/REFRACTORY SOLID TUMORS
2022-11-070
OA
Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo
2022-06-026
OAAI
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas
2021-12-188
OA
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
2021-11-1818
OAAI
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+Cells
2020-09-1035
OAAI
Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders
2020-04-1046
OAAI
De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy
AUTOPHAGY
IF14.3
2019-09-1372
OAAI
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer (vol 38, pg 1717, 2019)
2019-05-300
OAAI
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
2018-10-2328
OAAI